ADVERUM BIOTECHNOLOGIES, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • March 29th, 2022 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 29th, 2022 Company Industry JurisdictionThis Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between [_____________________] (“Executive”) and Adverum Biotechnologies, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
December 3, 2021 Setareh Seyedkazemi [Address] Re: Employment Offer, Chief Development Officer Dear Setareh,Adverum Biotechnologies, Inc. • March 29th, 2022 • Biological products, (no disgnostic substances) • California
Company FiledMarch 29th, 2022 Industry JurisdictionIf you decide to join us, this letter agreement (the “Agreement”) memorializes your compensation and other employment terms. These terms will become effective on the date you join the Company (the “Hire Date”).
SECOND AMENDMENT TO LEASE (PARTIAL LEASE TERMINATION)Partial Lease Termination) • March 29th, 2022 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 29th, 2022 Company Industry JurisdictionThis Second Amendment to Lease (Partial Lease Termination) (this “Second Amendment”) is entered into as of the 1st day of November, 2021, by and between HCP LS REDWOOD CITY, LLC, a Delaware limited liability company (“Landlord”), and ADVERUM BIOTECHNOLOGIES, INC., a Delaware corporation (“Tenant”).
SUBLEASE (REDWOOD CITY, CALIFORNIA)Sublease • March 29th, 2022 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 29th, 2022 Company Industry JurisdictionTHIS SUBLEASE (this “Sublease”) is entered into as of November 1, 2021 (the “Effective Date”), by and between REVOLUTION MEDICINES, INC., a Delaware corporation (“Sublandlord”), and ADVERUM BIOTECHNOLOGIES, INC., a Delaware corporation (“Subtenant”). Sublandlord and Subtenant may each be referred to herein as a “Party”, and collectively, the “Parties”.
ContractAgreement of Sublease • March 29th, 2022 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 29th, 2022 Company IndustryTHIS AGREEMENT OF SUBLEASE (“Sublease”) made as of the 26th day of October, 2021, by and between ADVERUM NC, LLC (“Sublandlord”) and JAGUAR GENE THERAPY, LLC (“Subtenant”).